Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies
The purpose of this study is to evaluate the potential inhibitory effects of patupilone on metabolism using midazolam and omeprazole as the respective probe drugs.
Solid Tumors
DRUG: Patupilone and Omeprazole|DRUG: Patupilone + Midalzolam
To evaluate the effects of patupilone on the pharmacokinetics of midazolam in patients with advanced malignancies., Day 1 (0.5h, 1h, 1.5h, 3h, 4h, 6h, 8h, 12h, 24h, 36h, 48h), Day 29 (0.5h, 1h, 1.5h, 3h, 4h, 6h, 8h, 12h, 24h, 36h, 48h)|To evaluate the effects of patupilone on the pharmacokinetics of omeprazole in patients with advanced malignancies, Day 1 (0.33h (20m), 0.67h (40m), 1h, 1.5h, 2h, 2.5h, 3h, 4h, 6h, 8h, 10h, 12h)
To evaluate the safety and tolerability of Patupilone when administered concomitantly with midazolam in patients with advanced malignancies., at each visit (week 1, week 2, week 5, and end of study)|To evaluate the safety and tolerability of Patupilone when administered concomitantly with omeprazole in patients with advanced malignancies., at each visit (week 1, week 2, week 5, and end of study)
The purpose of this study is to evaluate the potential inhibitory effects of patupilone on metabolism using midazolam and omeprazole as the respective probe drugs.